The ELIXA trial assessed CV safety associated with lixisenatide versus placebo in >6000 patients with T2D and a recent acute coronary syndrome. 3 This module details the CV outcomes and safety results from the trial.
ELIXA Trial
ELIXA: study design
ELIXA: baseline characteristics (1/2)
ELIXA: baseline characteristics (2/2)
ELIXA: renal function at baseline
ELIXA: glucose-lowering medications at baseline
ELIXA: CV medications at baseline
ELIXA: primary outcome 4P-MACE
ELIXA: components of 4P-MACE
ELIXA: subgroup analysis of 4P-MACE (1/4)
ELIXA: subgroup analysis of 4P-MACE (2/4)
ELIXA: subgroup analysis of 4P-MACE (3/4)
ELIXA: subgroup analysis of 4P-MACE (4/4)
ELIXA: heart failure endpoints
ELIXA: metabolic parameters (1/2)
ELIXA: metabolic parameters (2/2)
ELIXA safety outcomes (1/2)
ELIXA safety outcomes (2/2)
ELIXA safety outcomes: adverse events leading to discontinuation (1/2)
ELIXA safety outcomes: adverse events leading to discontinuation (2/2)
ELIXA: summary
Rate this content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content
Login or create an account to see restricted content